VSNL1 Promotes Gastric Cancer Cell Proliferation and Migration by Regulating P2X3/P2Y2 Receptors and Is a Clinical Indicator of Poor Prognosis in Gastric Cancer Patients

Figure 3

VSNL1 expression determined in gastric cancer lesions and noncancerous tissues by IHC; magnification: ×200. (a) VSNL1 was weakly expressed in noncancerous tissues. (b, c) VSNL1 was mainly localized in the cytoplasm of cancer cells; VSNL1 was highly expressed in moderately differentiated adenocarcinoma. (d) VSNL1 was highly expressed in poorly differentiated adenocarcinoma.

(a)

(b)

(c)

(d)